Published in Life Sci on May 11, 2012
Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice. Am J Physiol Lung Cell Mol Physiol (2014) 0.84
Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol Neurodegener (2014) 0.83
Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease. Ageing Res Rev (2016) 0.80
Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity. PLoS Biol (2016) 0.79
Reduced right frontal fractional anisotropy correlated with early elevated plasma LDL levels in obese young adults. PLoS One (2014) 0.78
Role of LDL cholesterol and endolysosomes in amyloidogenesis and Alzheimer's disease. J Neurol Neurophysiol (2014) 0.77
Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation. J Alzheimers Dis (2015) 0.76
Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit. Austin J Pharmacol Ther (2014) 0.75
DNA Repair Interacts with Autophagy To Regulate Inflammatory Responses to Pulmonary Hyperoxia. J Immunol (2017) 0.75
Role of Endolysosomes in Skeletal Muscle Pathology Observed in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease. Front Aging Neurosci (2016) 0.75
Hypercholesterolemia induces short-term spatial memory impairments in mice: up-regulation of acetylcholinesterase activity as an early and causal event? J Neural Transm (Vienna) (2013) 0.75
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science (1993) 33.32
Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25
Alzheimer's disease is a synaptic failure. Science (2002) 13.82
Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19
Alzheimer's disease. Lancet (2006) 9.15
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet (1994) 7.07
Role of cholesterol and lipid organization in disease. Nature (2005) 5.07
Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci (2008) 4.63
Genetic associations with human longevity at the APOE and ACE loci. Nat Genet (1994) 4.17
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem (2009) 3.45
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem (1987) 3.04
Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci (2007) 2.96
Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem (2004) 2.85
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol (2000) 2.78
Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet (2009) 2.69
Mutagenesis identifies new signals for beta-amyloid precursor protein endocytosis, turnover, and the generation of secreted fragments, including Abeta42. J Biol Chem (1999) 2.57
Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A (2004) 2.32
Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp Neurol (1994) 2.25
The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis. Neurobiol Aging (2009) 2.12
Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases. Neurobiol Aging (2005) 2.08
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging (2006) 2.03
Synaptic vesicles retain their identity through the endocytic cycle. Nature (1998) 1.92
Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol Aging (2004) 1.88
Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem (2003) 1.86
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res (1992) 1.83
Two distinct pools of synaptic vesicles in single presynaptic boutons in a temperature-sensitive Drosophila mutant, shibire. Neuron (1998) 1.82
The neuropathogenic contributions of lysosomal dysfunction. J Neurochem (2002) 1.72
Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation (2003) 1.69
Efficient inhibition of the Alzheimer's disease beta-secretase by membrane targeting. Science (2008) 1.67
Alzheimer disease. Dis Mon (2010) 1.64
Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J Alzheimers Dis (2008) 1.61
Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later. Dement Geriatr Cogn Disord (2009) 1.58
Lipid imbalance in the neurological disorder, Niemann-Pick C disease. FEBS Lett (2006) 1.57
Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci (2008) 1.54
BACE is degraded via the lysosomal pathway. J Biol Chem (2005) 1.53
Cholesterol accumulation is associated with lysosomal dysfunction and autophagic stress in Npc1 -/- mouse brain. Am J Pathol (2007) 1.46
Intraneuronal compartments of the amyloid precursor protein. J Neurosci (1993) 1.41
High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem (2008) 1.41
Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res (1994) 1.31
High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp Neurol (2006) 1.31
Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease. Semin Cell Dev Biol (2008) 1.25
Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J Neurosci (2002) 1.24
Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J Biol Chem (2003) 1.22
The neuronal form of adaptor protein-3 is required for synaptic vesicle formation from endosomes. J Neurosci (2001) 1.22
Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation (2008) 1.22
The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann N Y Acad Sci (1999) 1.20
Effects of cellular cholesterol loading on macrophage foam cell lysosome acidification. J Lipid Res (2007) 1.19
Is the apoE4 allele an independent predictor of coronary events? Am J Med (2001) 1.18
Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease? J Neuropathol Exp Neurol (2003) 1.18
Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res (1990) 1.18
Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc Res Tech (2000) 1.17
Marked differences in cholesterol synthesis between neurons and glial cells from postnatal rats. J Neurochem (2009) 1.15
Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol (1999) 1.13
Lipid dynamics in neurons. Biochem Soc Trans (2006) 1.11
Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice. J Biol Chem (2001) 1.08
Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J Neurochem (1997) 1.08
Expression of beta-amyloid precursor protein-CD3gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments. J Biol Chem (1999) 1.07
Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-beta by cathepsin D. J Biol Chem (1994) 1.06
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem (2008) 1.04
Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging (2004) 1.03
The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective. J Alzheimers Dis (2004) 1.02
Synaptic and endosomal localization of active gamma-secretase in rat brain. PLoS One (2010) 1.02
Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem (1996) 1.02
Crystal structure of an active form of BACE1, an enzyme responsible for amyloid beta protein production. Mol Cell Biol (2008) 1.02
Beyond amyloid: the next generation of Alzheimer's disease therapeutics. Mol Interv (2007) 1.01
Autophagic-lysosomal dysfunction and neurodegeneration in Niemann-Pick Type C mice: lipid starvation or indigestion? Autophagy (2007) 0.97
Evidence that secretase cleavage of cell surface Alzheimer amyloid precursor occurs after normal endocytic internalization. J Neurosci Res (1995) 0.96
Cholesterol storage and tau pathology in Niemann-Pick type C disease in the brain. J Pathol (2003) 0.95
Intracellular deposition, microtubule destabilization, and transport failure: an "early" pathogenic cascade leading to synaptic decline. J Neuropathol Exp Neurol (2002) 0.95
Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease. Neurosci Res (1998) 0.93
The early and ongoing experience with the cholesterol-fed rabbit as a model of Alzheimer's disease: the old, the new and the pilot. J Alzheimers Dis (2008) 0.93
Degradation of nicastrin involves both proteasome and lysosome. J Neurochem (2007) 0.90
Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet. J Alzheimers Dis (2010) 0.88
Cathepsin D is involved in the clearance of Alzheimer's beta-amyloid protein. FEBS Lett (1996) 0.88
Late endocytic dysfunction as a putative cause of amyloid fibril formation in Alzheimer's disease. J Neurochem (2009) 0.88
Cholesterol in Alzheimer's disease and other amyloidogenic disorders. Subcell Biochem (2010) 0.87
Effects of high cholesterol diet on gliosis in apolipoprotein E knockout mice. Implications for Alzheimer's disease and stroke. Neurosci Lett (2004) 0.87
Targeting the role of the endosome in the pathophysiology of Alzheimer's disease: a strategy for treatment. Sci Aging Knowledge Environ (2006) 0.87
Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice. Histochem Cell Biol (2009) 0.85
Cholesterol changes in Alzheimer's disease: methods of analysis and impact on the formation of enlarged endosomes. Biochim Biophys Acta (2010) 0.85
Apolipoprotein B immunoreactivity in senile plaque and vascular amyloids and neurofibrillary tangles in the brains of patients with Alzheimer's disease. Neurosci Lett (1992) 0.84
Processing of beta-amyloid precursor protein by cathepsin D. J Biol Chem (1996) 0.82
Lysosomal dysfunction produces distinct alterations in synaptic alpha-amino-3-hydroxy-5-methylisoxazolepropionic acid and N-methyl-D-aspartate receptor currents in hippocampus. J Neuropathol Exp Neurol (2007) 0.80
Apolipoprotein E genotype and the rate of decline in probable Alzheimer disease. Arch Neurol (1996) 0.79
Endosomal abnormalities related to amyloid precursor protein in cholesterol treated cerebral cortex neuronal cells derived from trisomy 16 mice, an animal model of Down syndrome. Neurosci Lett (2007) 0.78
Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann Neurol (2006) 2.74
A ketogenic diet suppresses seizures in mice through adenosine A₁ receptors. J Clin Invest (2011) 1.79
TOPGAL mice show that the canonical Wnt signaling pathway is active during bone development and growth and is activated by mechanical loading in vitro. J Bone Miner Res (2005) 1.68
Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep. J Neurosci (2002) 1.58
Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem (2009) 1.45
GABA(B) receptor activation inhibits neuronal excitability and spatial learning in the entorhinal cortex by activating TREK-2 K+ channels. Neuron (2009) 1.27
Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment. Chem Biol (2011) 1.25
Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease. J Neuroinflammation (2008) 1.22
Presence and functional significance of presynaptic ryanodine receptors. Prog Neurobiol (2003) 1.12
Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol Dis (2007) 1.09
Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets? Trends Neurosci (2008) 1.07
Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability. J Neurosci (2010) 1.06
Doping-control urinalysis of a ginseng extract, Cold-FX, in athletes. Int J Sport Nutr Exerc Metab (2004) 1.06
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem (2008) 1.04
Ethanol alters glutamate but not adenosine uptake in rat astrocytes: evidence for protein kinase C involvement. Neurochem Res (2002) 1.02
Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis (2010) 1.01
Caffeine protects against oxidative stress and Alzheimer's disease-like pathology in rabbit hippocampus induced by cholesterol-enriched diet. Free Radic Biol Med (2010) 0.99
Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity. Eur J Pharmacol (2004) 0.97
Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90. Mol Cell Biochem (2010) 0.93
Angiotensin II/angiotensin II type I receptor (AT1R) signaling promotes MCF-7 breast cancer cells survival via PI3-kinase/Akt pathway. J Cell Physiol (2010) 0.93
A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease. Physiol Behav (2011) 0.92
Role of endolysosomes in HIV-1 Tat-induced neurotoxicity. ASN Neuro (2012) 0.92
Evidence of oxidative stress-induced BNIP3 expression in amyloid beta neurotoxicity. Brain Res (2007) 0.90
Enzymes of adenosine metabolism in the brain: diurnal rhythm and the effect of sleep deprivation. J Neurochem (2003) 0.89
Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production. Neurobiol Aging (2013) 0.89
The PTHrP functional domain is at the gates of endochondral bones. Ann N Y Acad Sci (2007) 0.89
Assessment of post-mortem-induced changes to the mouse brain proteome. J Neurochem (2007) 0.89
Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet. J Alzheimers Dis (2010) 0.88
Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels. J Neurophysiol (2008) 0.88
Homeostatic bioenergetic network regulation - a novel concept to avoid pharmacoresistance in epilepsy. Expert Opin Drug Discov (2011) 0.88
A sensitive HPLC-based method to quantify adenine nucleotides in primary astrocyte cell cultures. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.86
Angiotensin II suppresses adriamycin-induced apoptosis through activation of phosphatidylinositol 3-kinase/Akt signaling in human breast cancer cells. Acta Biochim Biophys Sin (Shanghai) (2008) 0.85
Knockdown of osteopontin chemosensitizes MDA-MB-231 cells to cyclophosphamide by enhancing apoptosis through activating p38 MAPK pathway. Cancer Biother Radiopharm (2011) 0.85
Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer. J Exp Clin Cancer Res (2014) 0.84
Informed decision-making on sympathomimetic use in sport and health. Clin J Sport Med (2002) 0.83
Aβ42-binding peptoids as amyloid aggregation inhibitors and detection ligands. ACS Chem Neurosci (2013) 0.81
Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis. Am J Physiol Regul Integr Comp Physiol (2008) 0.81
Purines and the Anti-Epileptic Actions of Ketogenic Diets. Open Neurosci J (2010) 0.80
Microwave irradiation decreases ATP, increases free [Mg²⁺], and alters in vivo intracellular reactions in rat brain. J Neurochem (2012) 0.80
Ketone bodies protection against HIV-1 Tat-induced neurotoxicity. J Neurochem (2012) 0.80
Targeted glycomics by selected reaction monitoring for highly sensitive glycan compositional analysis. Proteomics (2012) 0.79
Neuroprotective actions of pyridoxine. Biochim Biophys Acta (2003) 0.78
The ketogenic diet and epilepsy: is adenosine the missing link? Epilepsia (2009) 0.78
Purine level regulation during energy depletion associated with graded excitatory stimulation in brain. Neurol Res (2005) 0.77
Computational methods for DNA-binding protein and binding residue prediction. Protein Pept Lett (2013) 0.77
Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury. Curr HIV Res (2014) 0.77
Impaired agonist-dependent myosin phosphorylation and decreased RhoA in rat portal hypertensive mesenteric vasculature. Am J Physiol Gastrointest Liver Physiol (2004) 0.77
Caffeine, Through Adenosine A3 Receptor-Mediated Actions, Suppresses Amyloid-β Protein Precursor Internalization and Amyloid-β Generation. J Alzheimers Dis (2015) 0.76
Cellular Interactions and Signaling in neuroAIDS: Emerging Issues Colloquium. J Neuroimmune Pharmacol (2014) 0.76
Altered Cholesterol Intracellular Trafficking and the Development of Pathological Hallmarks of Sporadic AD. J Parkinsons Dis Alzheimers Dis (2015) 0.76
Ryanodine receptor modulation by diadenosine polyphosphates in synaptosomal and microsomal preparations of rat brain. Eur J Pharmacol (2003) 0.75
Acetate supplementation modulates brain adenosine metabolizing enzymes and adenosine A₂A receptor levels in rats subjected to neuroinflammation. J Neuroinflammation (2014) 0.75
Magnesium lithospermate B protects neurons from N-methyl-D-aspartic acid injury and attenuates kainic acid-induced neurodegeration in FVB mice. J Mol Neurosci (2013) 0.75
Shared gene regulation during human somatic cell reprogramming. J Genet Genomics (2012) 0.75
[Analysis of diagnosis and treatment for blunt trauma in the neck]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (2013) 0.75
[Application of portable esophageal dilator in treatment of esophageal stenosis at home]. Lin Chuang Er Bi Yan Hou Ke Za Zhi (2006) 0.75
Computational simulation study on the anion recognition properties of functionalized tetraphenyl porphyrins. J Mol Model (2015) 0.75
Survival analysis of patients with unilateral and bilateral primary breast cancer in Northeast China. Breast Cancer (2014) 0.75